Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron for preoperative anemia in lower extremity peripheral artery disease surgery
2018-003714-40Phase 4Active
- Sponsor
- Hospital Universitario Cruces
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferric carboxymaltose, ferrous sulfate and ferrous sulfate dihydrate in anaemia, arteriosclerosis obliterans and chronic limb-threatening ischaemia (CLTI) (2 arms), sponsored by Hospital Universitario Cruces. Primary endpoint: Incidence of blood transfusion. Started Apr 2019; status: active.
02
Drugs
ferric carboxymaltoseferrous sulfateferrous sulfate dihydrate
03
Conditions
anaemiaarteriosclerosis obliteranschronic limb-threatening ischaemia (CLTI)
Beyond the preview
Go deeper on 2018-003714-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003714-40.